ABT — Abbott Laboratories Share News
0.000.00%
Last trade - 00:00- $190.39bn
- $217.85bn
- $44.33bn
Brief: Abbott Receives FDA Approval For Its Tactiflex™ Duo Ablation Catheter To Treat People With Abnormal Heart Rhythms
Factbox: US companies face rise in cyber attacks
Factbox: US companies face rise in cyber attacks
Brief: Abbott's Next-Generation Amulet 360™ Device Receives CE Mark To Treat People With Atrial Fibrillation At Risk Of Stroke
Boston Scientific hit by cyberattack, global operations affected (updated)
Factbox: US companies face rise in cyber attacks
Boston Scientific hit by cyberattack, global operations affected
FDA authorizes Abbott's wearable to monitor ketone and glucose in diabetes patients
Brief: FDA Authorizes First Wearable Device That Continuously Monitors Both Ketone Levels And Blood Sugar
U.S. RESEARCH ROUNDUP-Health Catalyst, Nektar Therapeutics, TIC Solutions
Press Digest: Wall Street Journal - August 21
Abbott to pay $670 million to settle some preterm infant formula cases (updated)
Brief: Abbott Reaches Agreements To Resolve A Portion Of Litigation Involving Its Specialty Formulas For Preterm Infants
Abbott reaches agreements to resolve portion of litigation over infant formula
Abbott settles appeal over $495 million infant formula verdict
U.S. STOCKS ON THE MOVEX-Abbott, Columbia Financial, Jabil
U.S. STOCKS ON THE MOVEX-Abbott, Columbia Financial, Jabil,
Abbott rises on Google Health tie-up for AI-powered glucose insights
Factbox: US companies face rise in cyber attacks